CMS Belgium assisted financial investors in connection with the EUR 4,1 million fundraising of Graftys, a Medtech company developing and manufacturing synthetic bone biomaterials. With this fundraising, Graftys aims at improving their existing product range and invest in innovative new solutions.
The capital of Graftys is shared between the four new investors (Innovation Fund, Noshaq/ex-Meuseinvest, The Club Deal and Go Capital), together with the initial shareholders.
The CMS team involved included Vincent Dirckx, Corporate Finance and M&A Partner, and Guillaume Beauthier, Corporate and M&A Associate.
